DealMaker announced as the 3rd fastest growing company in Canada

September 23, 2022

DealMaker announced as the 3rd fastest growing company in Canada

September 23, 2022, DealMaker, a leading digital capital raise platform, has been named Canada’s 3rd fastest growing companies by The Globe and Mail Report on Business annual survey from over 430 qualifying companies analyzed.

The Report on Business ranking of Canada’s Top Growing Companies ranks qualifying independent Canadian companies by the percentage of their revenue growth over three years.

Founded by two lawyers in the capital markets industry, the Toronto-based FinTech has built an e-commerce-style digital platform that enables companies to easily raise capital online and market capital raises to the broader public. Co-Founders Rebecca Kacaba and Mat Goldstein came up with the idea for DealMaker in 2015 while running a startup practice in their law firm.

“We saw a huge pain point in the market where our clients were suffering, where processes were expensive and obsolete, and it was ripe for disruption,” says Rebecca Kacaba, co-founder and CEO. “Our innovation is advancing the equity crowdfunding space by increasing access to capital to founders who previously have been under-funded while also providing pre-IPO investment opportunities for those not behind the gilded gates of Wall Street.”

The DealMaker platform allows brands to tap into fundraising solutions beyond traditional venture capital, by using the internet to help companies to turn their customers and fans into shareholders. Also called Equity or Investor Crowdfunding, DealMaker’s software facilitates raising capital across a variety of offering structures, including including Reg A, Reg CF, Reg D, OM and Private Placements.

To date, DealMaker has processed over $1.7Bn in transactions and over 650,000 investments - more than any counterparts or competitor in North America. DealMaker’s technology was deployed in eight of the 10 largest online capital raises globally in the past 14 months.

“What makes DealMaker truly unique is our focus on providing an end-to-end platform for merchants who are coming online to raise capital,” says Mat Goldstein, co-founder and Chief Strategy Officer. “From the initial identification of leads and prospects, our best-in-class conversion functionality, and even after the round is closed with our state-of-the-art transfer agent, DealMaker is a pioneer in developing the online relationship between companies and their shareholders. We aren’t just going to list an offering on a website - we are going to partner with you to develop an entirely new relationship with your stakeholders.”

With a staff of over 124 employees spanning Canada, the US, and South America - DealMaker is the new market leader in online capital formation. The firm has recently announced a huge milestone in the industry, taking over from FundAmerica as the pre-eminent API-driven solution to raising capital online.

Read Globe & Mail article.

‍

Monogram Case Study - DealMaker (Embed)

When VCs said no, Monogram turned to retail investors. That decision powered their rise from startup to publicly traded company—and even helped them raise an additional $13M privately after their Nasdaq debut.

The Challenge: Raising Capital on Their Terms

The Challenge: Raising on Their Terms

Monogram Technologies was founded with a bold vision: to revolutionize orthopedic surgery with a robotic joint replacement system using custom 3D-printed joints. The market for this technology is massive—approximately $19.6 billion, with over 1 million knee replacements per year. But it's a capital-intensive, regulation-heavy space—and traditional VCs weren't biting.

Instead of compromising, co-founders Dr. Doug Unis and Ben Sexson went all-in on a different path: retail capital. Why?

Control and ownership: Not only were they able to raise the capital they needed to grow the business—they did it on their own terms.
Long-term asset: They wanted to build an army of true believers who wanted to see the company succeed and would continue to reinvest over the years.
A value-add network: Raising from retail allowed Monogram to amass a waiting list of thousands of patients eager to participate in future trials.
Aligned incentives: Their mission to improve patient outcomes and build a better future for those struggling with joint pain resonated with retail investors.

The Power of Retail: Monogram's Capital Journey

Start Date	End Date	Type	Platform	Amount Raised	# Investors
3/13/19	3/31/20	A+	SeedInvest	$14,588,668	6,000
11/16/20	1/16/21	A+	StartEngine	$2,965,501	8,000
1/17/21	2/18/22	A+	StartEngine	$23,647,853	14,082
7/15/22	3/16/23	CF	DealMaker	$4,673,000	2,249
3/1/23	4/8/23	A+	Republic	$232,275	120
3/1/23	5/23/23	A+	DealMaker	$15,958,364	5,198
5/18/23	-	Nasdaq listing
7/24	10/24	Unit Offering	DealMaker	$12,990,103	2,745

Monogram Capital Raise Timeline

Monogram's first direct-to-investor raise was a $14.6M round in 2019. Since then, Monogram has raised retail capital six additional times, using Reg A+ as a springboard to a Nasdaq listing in 2023.

Each raise brought in new believers—and more importantly, kept bringing them back. That's the long-term power of retail capital. It's not just one campaign—it's a compounding asset that grows with the business.

$80M+

Raised across seven campaigns

~40,000

Investors championing Monogram's vision

20%

Of each raise came from previous investors

Marketing Excellence

DealMaker Reach provided strategic investor acquisition services, helping Monogram connect with the right audience through high-impact channels.

Premium Publications

Targeted campaigns in premium publications like Morning Brew captured qualified investors

High-Engagement Webinars

Engaging events that generated over $4.3 million in investments

Community Building

Strategic approaches that fostered a loyal shareholder base

Investment Momentum

Innovative approaches that amplified investment momentum

Monogram's Journey to Success

Monogram's journey has been defined by relentless innovation, strategic fundraising, and breakthrough advancements in robotic-assisted joint replacement. From early-stage research to a Nasdaq listing and beyond, Monogram's milestones reflect its evolution into a pioneering force in orthopedic surgery:

Filed its first patent application in 2017
Conducted clinical studies at UCLA and University of Nebraska
Expanded the team with key hires
Attracted a top-tier advisory board to guide clinical innovations
Signed their first distribution partnerships
Made headlines with cutting-edge live demonstrations
Secured 501(k) FDA clearance for the mBôs surgical system

Nasdaq Debut & Beyond

In May 2023, Monogram Orthopaedics successfully listed on the Nasdaq—a significant milestone offering liquidity and growth opportunities for the company.

For most companies, that would be the end of their story in the private markets. But for Monogram, it was just the beginning of a new chapter.

Public perception says you can't raise privately post-IPO. Monogram proved that wrong.

Defying conventional fundraising norms, Monogram raised an additional $13 million from private investors, powered by DealMaker. This move highlighted the power of a dedicated investor community and provided additional strategic growth capital. Meanwhile, strategic digital marketing for the private offering helped boost the public share price—a win-win for the company and its investors, both public and private.

This was retail capital at its best: strategic, repeatable, and aligned.

One vision. Zero compromises.

This wasn't a one-time raise. It was a multi-year capital strategy.

Retail capital helped Monogram:

Go from concept to commercialization without relying on VCs
Retain ownership and control in a high-burn industry
Build a base of loyal shareholders who invested not once, but over and over again
Uplist to the Nasdaq, and still keep raising post-IPO

This is what makes retail capital different. It doesn't expire—it compounds. And DealMaker is built to maximize that long-term value.

Ready to Raise Capital on Your Terms?

Whether you're pre-revenue or post-IPO, DealMaker gives you the infrastructure, support, and strategy to raise from the people who believe in you most.

Explore Raising Capital with DealMaker